[VRDN] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -26.24%
YoY- -24.63%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 168 828 880 695 2,514 372 476 -50.08%
PBT -6,435 -8,044 -10,118 -11,230 -8,896 -11,629 -10,317 -27.01%
Tax 33 27 50 133 204 339 289 -76.49%
NP -6,435 -8,044 -10,118 -11,230 -8,896 -11,629 -10,317 -27.01%
Tax Rate - - - - - - - -
Total Cost 6,603 8,872 10,998 11,925 11,410 12,001 10,793 -27.95%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -3,830.36 -971.50 -1,149.77 -1,615.83 -353.86 -3,126.08 -2,167.44 46.22%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -1.82 -2.65 -4.69 -5.42 -4.31 -5.65 -5.02 -49.18%
EPS Diluted -1.82 -2.65 -4.69 -5.42 -4.31 -5.65 -5.02 -49.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.